Article
Isoginkgetin and Madrasin are poor splicing inhibitors
medRxiv · 2024 · Michael Tellier, author Gilbert Ansa, author Shona Murphy, author
Key facts
| Title | Isoginkgetin and Madrasin are poor splicing inhibitors |
|---|---|
| First author | Michael Tellier, author Gilbert Ansa, author Shona Murphy, author |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2023.01.16.524270 |
| Devices mentioned | BK110039, K103302 |
| Product codes mentioned | JJH, JJX, KIT, MVU, NDS, NJT, OOI, PFT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1